Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 228 | $116,134,138 |
Sells | 4 | $198,660,583 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
15 Nov 2023 17:13 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 15 Nov 2023 | Purchase | 14,018 | 161.966 | 2,270,439 | I |
15 Nov 2023 17:13 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 14 Nov 2023 | Purchase | 31,530 | 156.4244 | 4,932,061 | I |
15 Nov 2023 17:13 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 15 Nov 2023 | Purchase | 1,181 | 161.966 | 191,282 | I |
15 Nov 2023 17:13 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 14 Nov 2023 | Purchase | 2,658 | 156.4244 | 415,776 | I |
17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 17 Aug 2023 | Purchase | 61,134 | 0.6928 | 42,354 | I |
17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 17 Aug 2023 | Purchase | 5,041 | 0.6928 | 3,492 | I |
17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 17 Aug 2023 | Purchase | 93,091 | 0.6924 | 64,456 | I |
17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 17 Aug 2023 | Purchase | 7,676 | 0.6924 | 5,315 | I |
17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 16 Aug 2023 | Purchase | 4,434 | 0.6828 | 3,028 | I |
17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 16 Aug 2023 | Purchase | 366 | 0.6828 | 250 | I |
17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 16 Aug 2023 | Purchase | 207,676 | 0.6805 | 141,324 | I |
17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 16 Aug 2023 | Purchase | 17,124 | 0.6805 | 11,653 | I |
17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 15 Aug 2023 | Purchase | 4,342 | 0.665 | 2,887 | I |
17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 15 Aug 2023 | Purchase | 358 | 0.665 | 238 | I |
17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 15 Aug 2023 | Purchase | 1,740,581 | 0.6308 | 1,097,958 | I |
17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 15 Aug 2023 | Purchase | 143,519 | 0.6308 | 90,532 | I |
06 Jun 2022 17:07 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 06 Jun 2022 | Purchase | 26,450 | 6.4215 | 169,849 | I |
06 Jun 2022 17:07 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 06 Jun 2022 | Purchase | 3,118 | 6.4215 | 20,022 | I |
06 Jun 2022 17:07 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 06 Jun 2022 | Purchase | 7,815 | 6.3537 | 49,654 | I |
06 Jun 2022 17:07 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 06 Jun 2022 | Purchase | 921 | 6.3537 | 5,852 | I |
06 Jun 2022 17:07 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 02 Jun 2022 | Purchase | 2,364 | 5.8202 | 13,759 | I |
06 Jun 2022 17:07 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 02 Jun 2022 | Purchase | 279 | 5.8202 | 1,624 | I |
24 May 2022 18:39 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 24 May 2022 | Purchase | 19,789 | 5.7415 | 113,619 | I |
24 May 2022 18:39 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 24 May 2022 | Purchase | 2,334 | 5.7415 | 13,401 | I |
24 May 2022 18:39 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 24 May 2022 | Purchase | 1,521 | 5.93 | 9,020 | I |
24 May 2022 18:39 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 24 May 2022 | Purchase | 179 | 5.93 | 1,061 | I |
24 May 2022 18:39 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 23 May 2022 | Purchase | 7,010 | 5.9874 | 41,972 | I |
24 May 2022 18:39 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 23 May 2022 | Purchase | 827 | 5.9874 | 4,952 | I |
24 May 2022 18:39 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 20 May 2022 | Purchase | 7,772 | 5.8421 | 45,405 | I |
24 May 2022 18:39 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 20 May 2022 | Purchase | 946 | 5.8421 | 5,527 | I |
24 May 2022 18:39 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 20 May 2022 | Purchase | 7,248 | 5.8409 | 42,335 | I |
24 May 2022 18:39 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 20 May 2022 | Purchase | 883 | 5.8409 | 5,158 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)